• EN
    • SV
  • About Us
    • Overview
    • Vision, mission, values
    • Our strategy
    • Executive Team
    • Board of Directors
    • Our history
  • Our Science
    • Overview
    • Ion channels
    • Publications/presentations
    • Partnerships & spinouts
    • The discovery process
  • Our Pipeline
    • Overview
    • Tesofensine
    • Tesomet
    • SAN903
    • SAN2219
    • SAN2355
    • SAN2465
    • The development process
  • Patients & Caregivers
    • Overview
    • Hypothalamic obesity
    • Prader-Willi syndrome
    • Epilepsy
    • Rare diseases
  • Investor Relations
    • Overview
    • The Share
    • Financial Calendar
    • Financial reports and filings
    • Analyst Coverage
    • Events and Presentations
    • FAQs
    • Corporate governance
  • Newsroom
    • Overview
    • Press Releases
    • Voices
    • Media Kit
  • Join Us
    • Overview
    • Working with us
    • Current Openings
Saniona
  • EN
  • SV
INVESTORS

Events and
Presentations

Saniona Icon blue
  • Overview
  • The Share
    • Share Information
    • Ownership Structure
  • Financial Calendar
  • Reports & Fillings
    • Annual & Quarterly Reports
    • Prospectus
    • Old prospectus
  • Analysts
  • Events and Presentations
  • FAQs
  • Corporate governance
    • Executive Team
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Shareholder Meetings
    • Nomination Committee
    • Auditors
    • Remuneration Incentive Programs

Corporate Presentation

To be updated

Past Events

Saniona’s CSO: “We are on track with SAN2219”
March 28, 2025
Presentation
Commercialization in Life Science
March 20, 2025
Presentation
Redeye Investor Forum Online
March 7, 2025
Presentation
Life Sciencedagen 2025
March 6, 2025
Presentation
BioStock interview with Saniona
February 11, 2025
Presentation
Aktiespararna – Life Science Event
January 29, 2025
Presentation
Redeye Technology & Life Science Day 2024
December 3, 2024
BIO-EUROPE, STOCKHOLM
November 4, 2024 - November 6, 2024
Redeye interview with our CEO Thomas Feldthus
June 13, 2024
Presentation
AKTIEINFO INVESTORARRANGEMENT – COPENHAGEN
March 21, 2024
Presentation
  • 1
  • 2
  • 3
  • …
  • 6
  • Next »

ABOUT US

Vision, mission, values

Our strategy

Executive team

Board of directors

Our history

OUR SCIENCE

Ion channels

Publications / presentations

Partnerships & spinouts

The discovery process

OUR PIPELINE

Tesofensine

Tesomet

SAN903

SAN2219

SAN2355

SAN2465

The development process

PATIENTS & CAREGIVERS

Hypothalamic obesity

Prader-Willi syndrome

Epilepsy

Rare diseases

INVESTORS

The share

Financial calendar

Financial reports and filings

Analyst coverage

Events and presentations

FAQs

Corporate Governance

NEWSROOM

Press releases

Voices

Media kit

 

JOIN US

Working with us

Current Openings

Saniona
DENMARK

Murervangen 42
DK-2600 Glostrup
Denmark
+45 7070 5225
saniona@saniona.com

CONNECT 
  • Follow
  • Follow
  • Follow

© 2025 Saniona. All rights reserved.

Privacy Policy